A citation-based method for searching scientific literature

Ellen L van Agtmaal, Laurène M André, Marieke Willemse, Sarah A Cumming, Ingeborg D G van Kessel, Walther J A A van den Broek, Geneviève Gourdon, Denis Furling, Vincent Mouly, Darren G Monckton, Derick G Wansink, Bé Wieringa. Mol Ther 2017
Times Cited: 75







List of co-cited articles
1475 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients.
Claudia Provenzano, Marisa Cappella, Rea Valaperta, Rosanna Cardani, Giovanni Meola, Fabio Martelli, Beatrice Cardinali, Germana Falcone. Mol Ther Nucleic Acids 2017
39
74

Elimination of Toxic Microsatellite Repeat Expansion RNA by RNA-Targeting Cas9.
Ranjan Batra, David A Nelles, Elaine Pirie, Steven M Blue, Ryan J Marina, Harrison Wang, Isaac A Chaim, James D Thomas, Nigel Zhang, Vu Nguyen,[...]. Cell 2017
140
30

Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells.
Sumitava Dastidar, Simon Ardui, Kshitiz Singh, Debanjana Majumdar, Nisha Nair, Yanfang Fu, Deepak Reyon, Ermira Samara, Mattia F M Gerli, Arnaud F Klein,[...]. Nucleic Acids Res 2018
49
46

A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Martin Jinek, Krzysztof Chylinski, Ines Fonfara, Michael Hauer, Jennifer A Doudna, Emmanuelle Charpentier. Science 2012
28

Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene.
M Mahadevan, C Tsilfidis, L Sabourin, G Shutler, C Amemiya, G Jansen, C Neville, M Narang, J Barceló, K O'Hoy. Science 1992
26

Targeting nuclear RNA for in vivo correction of myotonic dystrophy.
Thurman M Wheeler, Andrew J Leger, Sanjay K Pandey, A Robert MacLeod, Masayuki Nakamori, Seng H Cheng, Bruce M Wentworth, C Frank Bennett, Charles A Thornton. Nature 2012
328
26

Multiplex genome engineering using CRISPR/Cas systems.
Le Cong, F Ann Ran, David Cox, Shuailiang Lin, Robert Barretto, Naomi Habib, Patrick D Hsu, Xuebing Wu, Wenyan Jiang, Luciano A Marraffini,[...]. Science 2013
26

Impeding Transcription of Expanded Microsatellite Repeats by Deactivated Cas9.
Belinda S Pinto, Tanvi Saxena, Ruan Oliveira, Héctor R Méndez-Gómez, John D Cleary, Lance T Denes, Ona McConnell, Juan Arboleda, Guangbin Xia, Maurice S Swanson,[...]. Mol Cell 2017
63
31

Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy.
Yuanzheng Gao, Xiuming Guo, Katherine Santostefano, Yanlin Wang, Tammy Reid, Desmond Zeng, Naohiro Terada, Tetsuo Ashizawa, Guangbin Xia. Mol Ther 2016
35
54

Non-ATG-initiated translation directed by microsatellite expansions.
Tao Zu, Brian Gibbens, Noelle S Doty, Mário Gomes-Pereira, Aline Huguet, Matthew D Stone, Jamie Margolis, Mark Peterson, Todd W Markowski, Melissa A C Ingram,[...]. Proc Natl Acad Sci U S A 2011
562
22

Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.
A Mankodi, E Logigian, L Callahan, C McClain, R White, D Henderson, M Krym, C A Thornton. Science 2000
502
22

Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA.
Thurman M Wheeler, Krzysztof Sobczak, John D Lueck, Robert J Osborne, Xiaoyan Lin, Robert T Dirksen, Charles A Thornton. Science 2009
279
21

Contracting CAG/CTG repeats using the CRISPR-Cas9 nickase.
Cinzia Cinesi, Lorène Aeschbach, Bin Yang, Vincent Dion. Nat Commun 2016
47
34

RNA-guided human genome engineering via Cas9.
Prashant Mali, Luhan Yang, Kevin M Esvelt, John Aach, Marc Guell, James E DiCarlo, Julie E Norville, George M Church. Science 2013
21

In vivo gene editing in dystrophic mouse muscle and muscle stem cells.
Mohammadsharif Tabebordbar, Kexian Zhu, Jason K W Cheng, Wei Leong Chew, Jeffrey J Widrick, Winston X Yan, Claire Maesner, Elizabeth Y Wu, Ru Xiao, F Ann Ran,[...]. Science 2016
628
21

Genome modification leads to phenotype reversal in human myotonic dystrophy type 1 induced pluripotent stem cell-derived neural stem cells.
Guangbin Xia, Yuanzheng Gao, Shouguang Jin, S H Subramony, Naohiro Terada, Laura P W Ranum, Maurice S Swanson, Tetsuo Ashizawa. Stem Cells 2015
42
35

Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy.
Chengzu Long, Leonela Amoasii, Alex A Mireault, John R McAnally, Hui Li, Efrain Sanchez-Ortiz, Samadrita Bhattacharyya, John M Shelton, Rhonda Bassel-Duby, Eric N Olson. Science 2016
581
20


Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.
C L Liquori, K Ricker, M L Moseley, J F Jacobsen, W Kress, S L Naylor, J W Day, L P Ranum. Science 2001
836
18

Splicing biomarkers of disease severity in myotonic dystrophy.
Masayuki Nakamori, Krzysztof Sobczak, Araya Puwanant, Steve Welle, Katy Eichinger, Shree Pandya, Jeannne Dekdebrun, Chad R Heatwole, Michael P McDermott, Tian Chen,[...]. Ann Neurol 2013
137
18


In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.
Christopher E Nelson, Chady H Hakim, David G Ousterout, Pratiksha I Thakore, Eirik A Moreb, Ruth M Castellanos Rivera, Sarina Madhavan, Xiufang Pan, F Ann Ran, Winston X Yan,[...]. Science 2016
682
18

Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9.
Yanlin Wang, Lei Hao, Hongcai Wang, Katherine Santostefano, Arjun Thapa, John Cleary, Hui Li, Xiuming Guo, Naohiro Terada, Tetsuo Ashizawa,[...]. Mol Ther 2018
26
53

Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.
J D Brook, M E McCurrach, H G Harley, A J Buckler, D Church, H Aburatani, K Hunter, V P Stanton, J P Thirion, T Hudson. Cell 1992
17

Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy.
Susan A M Mulders, Walther J A A van den Broek, Thurman M Wheeler, Huib J E Croes, Petra van Kuik-Romeijn, Sjef J de Kimpe, Denis Furling, Gerard J Platenburg, Geneviève Gourdon, Charles A Thornton,[...]. Proc Natl Acad Sci U S A 2009
190
17

A muscleblind knockout model for myotonic dystrophy.
Rahul N Kanadia, Karen A Johnstone, Ami Mankodi, Codrin Lungu, Charles A Thornton, Douglas Esson, Adrian M Timmers, William W Hauswirth, Maurice S Swanson. Science 2003
529
17

CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo.
Alex Mas Monteys, Shauna A Ebanks, Megan S Keiser, Beverly L Davidson. Mol Ther 2017
151
17

Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.
J W Miller, C R Urbinati, P Teng-Umnuay, M G Stenberg, B J Byrne, C A Thornton, M S Swanson. EMBO J 2000
644
17

Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9.
Hongmei Lisa Li, Naoko Fujimoto, Noriko Sasakawa, Saya Shirai, Tokiko Ohkame, Tetsushi Sakuma, Michihiro Tanaka, Naoki Amano, Akira Watanabe, Hidetoshi Sakurai,[...]. Stem Cell Reports 2015
326
17


Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells.
Majid Fardaei, Mark T Rogers, Helena M Thorpe, Kenneth Larkin, Marion G Hamshere, Peter S Harper, J David Brook. Hum Mol Genet 2002
332
16

RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1.
Johanna E Lee, C Frank Bennett, Thomas A Cooper. Proc Natl Acad Sci U S A 2012
104
16

Generation of neural cells from DM1 induced pluripotent stem cells as cellular model for the study of central nervous system neuropathogenesis.
Guangbin Xia, Katherine E Santostefano, Marianne Goodwin, Jilin Liu, S H Subramony, Maurice S Swanson, Naohiro Terada, Tetsuo Ashizawa. Cell Reprogram 2013
33
36

Highly specific contractions of a single CAG/CTG trinucleotide repeat by TALEN in yeast.
Guy-Franck Richard, David Viterbo, Varun Khanna, Valentine Mosbach, Lauriane Castelain, Bernard Dujon. PLoS One 2014
39
30


Precise small-molecule recognition of a toxic CUG RNA repeat expansion.
Suzanne G Rzuczek, Lesley A Colgan, Yoshio Nakai, Michael D Cameron, Denis Furling, Ryohei Yasuda, Matthew D Disney. Nat Chem Biol 2017
105
16

Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.
Niclas E Bengtsson, John K Hall, Guy L Odom, Michael P Phelps, Colin R Andrus, R David Hawkins, Stephen D Hauschka, Joel R Chamberlain, Jeffrey S Chamberlain. Nat Commun 2017
211
16

A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells.
Courtney S Young, Michael R Hicks, Natalia V Ermolova, Haruko Nakano, Majib Jan, Shahab Younesi, Saravanan Karumbayaram, Chino Kumagai-Cresse, Derek Wang, Jerome A Zack,[...]. Cell Stem Cell 2016
211
16

Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 Mice.
Mirella Lo Scrudato, Karine Poulard, Célia Sourd, Stéphanie Tomé, Arnaud F Klein, Guillaume Corre, Aline Huguet, Denis Furling, Geneviève Gourdon, Ana Buj-Bello. Mol Ther 2019
21
57

Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease.
Ranjan Batra, Konstantinos Charizanis, Mini Manchanda, Apoorva Mohan, Moyi Li, Dustin J Finn, Marianne Goodwin, Chaolin Zhang, Krzysztof Sobczak, Charles A Thornton,[...]. Mol Cell 2014
176
14

Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification.
M De Antonio, C Dogan, D Hamroun, M Mati, S Zerrouki, B Eymard, S Katsahian, G Bassez. Rev Neurol (Paris) 2016
106
14

Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy.
David G Ousterout, Ami M Kabadi, Pratiksha I Thakore, William H Majoros, Timothy E Reddy, Charles A Gersbach. Nat Commun 2015
268
14


Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
Ludovic Arandel, Micaela Polay Espinoza, Magdalena Matloka, Audrey Bazinet, Damily De Dea Diniz, Naïra Naouar, Frédérique Rau, Arnaud Jollet, Frédérique Edom-Vovard, Kamel Mamchaoui,[...]. Dis Model Mech 2017
49
22

Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.
F Ann Ran, Patrick D Hsu, Chie-Yu Lin, Jonathan S Gootenberg, Silvana Konermann, Alexandro E Trevino, David A Scott, Azusa Inoue, Shogo Matoba, Yi Zhang,[...]. Cell 2013
14


Reducing levels of toxic RNA with small molecules.
Leslie A Coonrod, Masayuki Nakamori, Wenli Wang, Samuel Carrell, Cameron L Hilton, Micah J Bodner, Ruth B Siboni, Aaron G Docter, Michael M Haley, Charles A Thornton,[...]. ACS Chem Biol 2013
55
20

Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy.
Rahul N Kanadia, Jihae Shin, Yuan Yuan, Stuart G Beattie, Thurman M Wheeler, Charles A Thornton, Maurice S Swanson. Proc Natl Acad Sci U S A 2006
247
13

Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9.
Jun Wan Shin, Kyung-Hee Kim, Michael J Chao, Ranjit S Atwal, Tammy Gillis, Marcy E MacDonald, James F Gusella, Jong-Min Lee. Hum Mol Genet 2016
130
13

Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.
Nicolas Charlet-B, Rajesh S Savkur, Gopal Singh, Anne V Philips, Elizabeth A Grice, Thomas A Cooper. Mol Cell 2002
427
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.